2312-0541

ERJ Open Research

European Respiratory Society

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 964 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact964 DOIs
2

Attach ORCID iDs across 632 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact632 DOIs
3

Add license metadata to 332 records

License metadata tells indexers and readers how each article may be reused.

Low impact332 DOIs

DOIs for this ISSN

Showing the top 5 of 3323 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The Nijmegen Questionnaire and dysfunctional breathing (10.1183/23120541.00001-2015)
Abstract ORCID License
155.39 117
2 Summary of the international clinical guidelines for the man… (10.1183/23120541.00028-2018)
Abstract ORCID License
133.90 60
3 Sarcoidosis: patient treatment priorities (10.1183/23120541.00141-2018)
Abstract ORCID License
133.90 60
4 Pembrolizumab-induced pneumonitis (10.1183/23120541.00081-2016)
Abstract ORCID License
112.89 31
5 The EMBARC European Bronchiectasis Registry: protocol for an… (10.1183/23120541.00081-2015)
ORCID License
111.78 171
6 Pulmonary veno-occlusive disease is highly prevalent in scle… (10.1183/23120541.00168-2018)
Abstract ORCID License
108.54 27
7 MMP-7 is a predictive biomarker of disease progression in pa… (10.1183/23120541.00074-2016)
ORCID License
104.85 124
8 Management of the patient with eosinophilic asthma: a new er… (10.1183/23120541.00024-2015)
ORCID License
104.67 123
9 IQOS exposure impairs human airway cell homeostasis: direct… (10.1183/23120541.00159-2018)
Abstract License
102.65 112
10 Outcomes of immunosuppressive therapy in chronic hypersensit… (10.1183/23120541.00016-2017)
ORCID License
102.46 111
11 Influenza: from zoonosis to pandemic (10.1183/23120541.00013-2016)
Abstract ORCID License
102.13 22
12 Incidence and predictive factors of lung cancer in patients… (10.1183/23120541.00111-2016)
ORCID License
101.27 105
13 Spacer devices for inhaled therapy: why use them, and how? (10.1183/23120541.00065-2018)
ORCID License
100.64 102
14 Maternal smoking in pregnancy and its influence on childhood… (10.1183/23120541.00042-2016)
ORCID License
100.22 100
15 Clinical profile of patients with adult-onset eosinophilic a… (10.1183/23120541.00100-2015)
ORCID License
100.22 100
16 Feasibility, utility and symptom impact of modified mindfuln… (10.1183/23120541.00085-2017)
Abstract ORCID License
99.17 20
17 Prevention of aerosol isolation of nontuberculous mycobacter… (10.1183/23120541.00150-2017)
Abstract ORCID License
99.17 20
18 COPD: time to improve its taxonomy? (10.1183/23120541.00132-2017)
ORCID License
98.66 93
19 Analysis of pulmonary features and treatment approaches in t… (10.1183/23120541.00017-2018)
ORCID License
98.19 91
20 A frequent phenotype for paediatric sleep apnoea: short ling… (10.1183/23120541.00043-2016)
ORCID License
98.19 91
21 The role of complement activation in COPD exacerbation recov… (10.1183/23120541.00027-2016)
Abstract ORCID License
97.58 19
22 Sleep disordered breathing: is it different for females? (10.1183/23120541.00063-2015)
Abstract ORCID License
97.58 19
23 Patterns, predictors and outcomes of asthma control and exac… (10.1183/23120541.00054-2015)
ORCID License
92.87 71
24 Palliative and end-of-life care conversations in COPD: a sys… (10.1183/23120541.00068-2016)
ORCID License
92.56 70
25 Integrated respiratory and palliative care may improve outco… (10.1183/23120541.00102-2017)
ORCID License
92.56 70
26 The cystic fibrosis lower airways microbial metagenome (10.1183/23120541.00096-2015)
ORCID License
91.30 66
27 New anti-tuberculosis drugs and regimens: 2015 update (10.1183/23120541.00010-2015)
ORCID License
89.62 61
28 Understanding asthma phenotypes: the World Asthma Phenotypes… (10.1183/23120541.00013-2018)
ORCID License
89.27 60
29 Physical activity assessed in routine care predicts mortalit… (10.1183/23120541.00062-2015)
ORCID License
88.91 59
30 Iatrogenic bleeding during flexible bronchoscopy: risk facto… (10.1183/23120541.00084-2016)
ORCID License
88.54 58
31 Systematic review of interventions to improve patient uptake… (10.1183/23120541.00089-2016)
ORCID License
88.54 58
32 An algorithmic approach for the treatment of severe uncontro… (10.1183/23120541.00125-2017)
ORCID License
88.17 57
33 The inflammasome pathway in stable COPD and acute exacerbati… (10.1183/23120541.00002-2016)
ORCID License
87.41 55
34 Psychological profile of individuals presenting with chronic… (10.1183/23120541.00099-2016)
ORCID License
85.80 51
35 Importance of serial changes in biomarkers in idiopathic pul… (10.1183/23120541.00019-2016)
ORCID License
83.60 46
36 Embolisation of PAVMs reported to improve nosebleeds by a su… (10.1183/23120541.00035-2016)
Abstract ORCID License
83.55 12
37 Variations in the prevalence of childhood asthma and wheeze… (10.1183/23120541.00150-2016)
ORCID License
83.14 45
38 Noninvasive ventilation in stable hypercapnic COPD: what is… (10.1183/23120541.00012-2018)
ORCID License
82.66 44
39 Attitudes and preferences of home mechanical ventilation use… (10.1183/23120541.00015-2017)
ORCID License
82.17 43
40 Exhaled breath hydrogen cyanide as a marker of early<i>Pseud… (10.1183/23120541.00044-2015)
ORCID License
81.67 42
41 Bulbar impairment score and survival of stable amyotrophic l… (10.1183/23120541.00159-2017)
ORCID License
81.16 41
42 Pulmonary arteriovenous malformations: evidence of physician… (10.1183/23120541.00104-2016)
Abstract ORCID License
80.94 11
43 Indoor air pollution and tobacco smoke exposure: impact on n… (10.1183/23120541.00052-2018)
ORCID License
80.64 40
44 Early diagnosis from newborn screening maximises survival in… (10.1183/23120541.00109-2017)
ORCID License
80.64 40
45 Natural history of COPD: gaps and opportunities (10.1183/23120541.00117-2017)
ORCID License
80.64 40
46 A multidisciplinary team case management approach reduces th… (10.1183/23120541.00039-2016)
ORCID License
80.10 39
47 High-altitude alpine therapy and lung function in asthma: sy… (10.1183/23120541.00097-2015)
ORCID License
80.10 39
48 Protected sampling is preferable in bronchoscopic studies of… (10.1183/23120541.00019-2017)
ORCID License
78.41 36
49 Chronic airflow obstruction after successful treatment of mu… (10.1183/23120541.00026-2017)
ORCID License
78.41 36
50 Pleural tuberculosis: medical thoracoscopy greatly increases… (10.1183/23120541.00046-2017)
ORCID License
78.41 36